School of Medicine


Showing 1-10 of 35 Results

  • Mark A. Cappelli

    Mark A. Cappelli

    Professor of Mechanical Engineering

    BioProfessor Cappelli received his B.Sc. degree in Physics (McGill, 1980), and M.A.Sc and Ph.D. degrees in Aerospace Sciences (Toronto, 1983, 1987). He joined Stanford University in 1987 and is currently a Professor in the Department of Mechanical Engineering and Co-Director of the Engineering Physics Program. He carries out research in applied plasma physics with applications to a broad range of fields, including space propulsion, aerodynamics, medicine, materials synthesis, and fusion.

  • Ian Carroll, MD, MS

    Ian Carroll, MD, MS

    Associate Professor of Anesthesiology, Perioperative and Pain Medicine (Adult Pain)

    Current Research and Scholarly InterestsWe are committed to promoting an understanding of cerebrospinal fluid (CSF) leaks, and ensuring that all patients who are suffering from cerebrospinal fluid leaks receive appropriate diagnosis and treatment of this devastating, chronic, and fixable condition. We believe this can be best accomplished in a multidisciplinary setting involving expertise in radiology, neurology, and interventional pain medicine.

  • Chris Cartwright, MD

    Chris Cartwright, MD

    Professor of Medicine (Gastroenterology and Hepatology), Emerita

    Current Research and Scholarly InterestsMolecular mechanisms of intestinal cell growth control; function and regulation of the Src family of tyrosine kinases in normal cells, and their deregulation in cancer cells.

  • Jennifer Caswell-Jin

    Jennifer Caswell-Jin

    Assistant Professor of Medicine (Oncology)

    Current Research and Scholarly InterestsMy research is on the translational application of next-generation sequencing technologies to breast cancer care: (1) the value of hereditary cancer genetic panel testing in clinical practice, (2) the mechanisms by which inherited genetic variants lead to breast cancer development, and (3) the analysis of somatic tumor sequencing data to inform understanding of breast tumorigenesis, metastasis, and development of resistance in response to therapeutics.

  • Alma-Martina Cepika

    Alma-Martina Cepika

    Assistant Professor of Surgery (General Surgery)

    BioDr. Cepika is an immunologist with an extensive background in human immunology, genomics, and translational research. Her goal is to understand the mechanisms governing immune tolerance, and leverage this knowledge towards developing new therapies.

    Dr. Cepika received her MD degree and a PhD in Immunology from the University of Zagreb School of Medicine in Croatia. There, she focused on the immunomonitoring of patients with lupus, identifying how circulating DNA levels changed with therapy. For her post-doctoral fellowship, she joined the lab of Dr. Virginia Pascual at the Baylor Institute for Immunology Research in Dallas, Texas. There, Dr. Cepika developed a multi-pronged in vitro stimulation assay, called the Tollgene assay, to evaluate the phenotype and function of blood leukocytes in patients with systemic juvenile idiopathic arthritis (sJIA). In combination with integrated bioinformatics analysis, this approach identified that sJIA patients have hyper-reactive monocytes, which primarily differentiate into macrophages rather than dendritic cells due to low expression of aryl hydrocarbon receptor.

    As an Instructor in the Department of Pediatrics at Stanford, Dr. Cepika worked with Dr. Maria Grazia Roncarolo to investigate the biology and clinical applications of human inducible regulatory T cells (Tregs) called type 1 regulatory T (Tr1) cells. As well, she has spearheaded the efforts to understand the resistance of human leukemia cells to T cell killing.

    Dr. Cepika's laboratory in the Department of Surgery will continue exploring the pathogenesis of human autoinflammatory conditions such as inflammatory bowel disease (IBD), the biology of human Tregs in the tumor microenvironment, and the role Tregs play in resistance to cancer immunotherapy.

  • Anne Lynn S. Chang, MD

    Anne Lynn S. Chang, MD

    Professor of Dermatology
    On Leave from 10/01/2025 To 11/30/2025

    Current Research and Scholarly InterestsMy two main research interests are:

    1) To better understand and treat patients with aggressive basal and squamous cell carcinomas

    2) To better understand the genetic and epigenetic mechanisms of healthy human skin aging and to translate these insights into better care of skin diseases enriched in older patients, particularly skin cancer and rosacea

  • Howard Y. Chang, MD, PhD

    Howard Y. Chang, MD, PhD

    Virginia and D. K. Ludwig Professor of Cancer Research, Professor of Genetics and, by courtesy, of Pathology
    On Leave from 12/16/2024 To 12/15/2026

    Current Research and Scholarly InterestsOur research is focused on how the activities of hundreds or even thousands of genes (gene parties) are coordinated to achieve biological meaning. We have pioneered methods to predict, dissect, and control large-scale gene regulatory programs; these methods have provided insights into human development, cancer, and aging.

  • James K. Chen

    James K. Chen

    Jauch Professor and Professor of Chemical and Systems Biology, of Developmental Biology and of Chemistry
    On Partial Leave from 09/01/2025 To 11/30/2025

    Current Research and Scholarly InterestsOur laboratory combines chemistry and developmental biology to investigate the molecular events that regulate embryonic patterning, tissue regeneration, and tumorigenesis. We are currently using genetic and small-molecule approaches to study the molecular mechanisms of Hedgehog signaling, and we are developing chemical technologies to perturb and observe the genetic programs that underlie vertebrate development.

  • Michelle M. Chen, MD, MHS, FACS

    Michelle M. Chen, MD, MHS, FACS

    Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS)

    BioDr. Chen is a fellowship-trained head and neck surgical oncologist with a board certification in otolaryngology and an assistant professor with the Stanford School of Medicine Department of Otolaryngology.

    Her practice focuses on the treatment of cancers that affect the head and neck. She has received additional training in microvascular reconstruction and transoral robotic surgery.

    Dr. Chen has an active lab involved in head and neck cancer health services research and her work has appeared in numerous journals, including The Journal of the American Medical Association, Cancer, Journal of the National Cancer Institute, and Journal of Clinical Oncology. She has also authored chapters in textbooks on head and neck cancer treatment.

    Dr. Chen is a member of the American Academy of Otolaryngology—Head & Neck Surgery (AAOHNS) and the American Head & Neck Society.